Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


A Phase II, Double-Blind, Randomized, Placebo-Controlled Non-inferiority Trial of EpiCept™ NP-1 Topical Cream (2% Ketamine / 4% Amitriptyline) vs. Oral Gabapentin in Postherpetic Neuralgia (PHN)


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT00475904

Organisation Name: EpiCept Corporation

Overal Status: Completed

Start Date: July 2007

Last Update: July 27, 2011

Lead Sponsor: EpiCept Corporation

Brief Summary: The purpose of this study is to compare EpiCept™ NP-1 Topical Cream (2% ketamine / 4% amitriptyline) vs. Oral Gabapentin in the treatment of Postherpetic Neuralgia (PHN)

Conditions:
  • Post Herpetic Neuralgia
  • PHN
  • Neuropathy
  • Nerve Pain


Total execution time in seconds: 0.43963408470154